vTv Therapeutics Inc. Unrealized Gain (Loss) on Investments
vTv Therapeutics Inc. (VTVT) reported Unrealized Gain (Loss) on Investments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2025-03-20
- vTv Therapeutics Inc. unrealized gain (loss) on investments for the quarter ending 2024-12-31 was $0.00.
- vTv Therapeutics Inc. unrealized gain (loss) on investments for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- vTv Therapeutics Inc. unrealized gain (loss) on investments for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- vTv Therapeutics Inc. unrealized gain (loss) on investments for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- vTv Therapeutics Inc. unrealized gain (loss) on investments for fiscal 2024 was $0.00.
- vTv Therapeutics Inc. unrealized gain (loss) on investments for fiscal 2023 was $0.00.
- vTv Therapeutics Inc. unrealized gain (loss) on investments for fiscal 2022 was -$3.58M, a 246.45% decline from fiscal 2021.
- vTv Therapeutics Inc. unrealized gain (loss) on investments for fiscal 2021 was $2.45M, a 42.33% decline from fiscal 2020.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | $0.00 derived: sum of 3 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | -$3.04M derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$3.04M derived: sum of 3 quarters · filed 2025-03-20 | -$2.44M derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | -$3.04M derived: sum of 2 quarters · filed 2025-03-20 | -$2.44M derived: sum of 3 quarters · filed 2025-03-20 | -$2.10M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-12-31 | -$3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$2.44M derived: sum of 2 quarters · filed 2025-03-20 | -$2.10M derived: sum of 3 quarters · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 |
| 2023-09-30 | $605.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $940.00K derived: sum of 2 quarters · filed 2024-11-12 | $3.04M 10-Q · filed 2024-11-12 | $2.46M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-06-30 | $335.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.44M 10-Q · filed 2024-08-08 | $1.85M derived: sum of 3 quarters · filed 2025-03-20 | $2.25M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-03-31 | $2.10M 10-Q · filed 2024-05-09 | $1.52M derived: sum of 2 quarters · filed 2025-03-20 | $1.92M derived: sum of 3 quarters · filed 2025-03-20 | $1.75M derived: sum of 4 quarters · filed 2025-03-20 |
| 2022-12-31 | -$587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$184.00K derived: sum of 2 quarters · filed 2025-03-20 | -$351.00K derived: sum of 3 quarters · filed 2025-03-20 | -$3.58M 10-K · filed 2025-03-20 |
| 2022-09-30 | $403.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $236.00K derived: sum of 2 quarters · filed 2023-11-09 | -$3.00M 10-Q · filed 2023-11-09 | -$2.36M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | -$167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$3.40M 10-Q · filed 2023-08-11 | -$2.77M derived: sum of 3 quarters · filed 2024-03-13 | -$3.85M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | -$3.23M 10-Q · filed 2023-05-11 | -$2.60M derived: sum of 2 quarters · filed 2024-03-13 | -$3.68M derived: sum of 3 quarters · filed 2024-03-13 | |
| 2021-12-31 | $634.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$449.00K derived: sum of 2 quarters · filed 2024-03-13 | $2.45M 10-K · filed 2024-03-13 | |
| 2021-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.81M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $2.90M 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $4.25M 10-K · filed 2023-03-06 |